Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 17 of 17 publications.

Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Granger AL, Fehnel SE, Levine KB, Jordan J, Clark RV. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric. 2008 Jan 1;11(1):32-43.

Granger AL, Fehnel SE, Hogue SL, Bennett L, Edin HM. An assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based survey. J Affect Disord. 2006 Feb 1;90(2-3):217-21.

Britt DM, Fehnel SE, Granger AL, Zhou X, Williams R. Quality of life and the prevalence of vasomotor symptoms in a population-based sample of peri- and post-menopausal women. Poster presented at the 12th Annual Conference of the International Society for Quality of Life Research; October 19, 2005. San Francisco, CA.

Tafesse E, Claxton A, Granger AL, Sanders J, Apelian D, Atillasoy E, Iloeje U. Estimates of health care costs for lamivudine-refractory chronic hepatitis b (CHB) patients. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):310.

Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS. Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol. 2004 Oct 6;501(1-3):111-9.

Walker EA, Picker MJ, Granger AL, Dykstra LA. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline. J Pharmacol Exp Ther. 2004 Jul;310(1):150-8.

Mast TC, DeMuro-Mercon CJ, Granger AL, Santanello N, Huyett J, Goldstone S. The psychosocial impact of human papilloma virus (HPV) and related interventions among heterosexual men (HSM) and men who have sex with men (MSM). Poster presented at the 21st International Papillomavirus Conference; February 2004.

Wincze J, Fehnel SE, McLeod LD, Granger AL, Merchant S. Development and initial testing of a new patient-reported questionnaire: erection quality scale. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research Sixth Annual European Congress; November 1, 2003. Barcelona, Spain. [abstract] Value Health. 2003 Nov; 6(6):709.

Allen RM, Granger AL, Dykstra LA. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor. J Pharmacol Exp Ther. 2003 Nov 1;307(2):785-92.

Granger AL, Fehnel SE, Bell T. Humanistic and financial impacts of restless legs syndrome form the patients' perspective. Poster presented at the 7th Congress of the European Federation of Neurological Societies; August 2003.

Wincze JP, Fehnel SE, McLeod LD, Granger AL, Merchant S. Development and initial testing of a new patient-reported questionnaire-erection quality scale. Value Health. 2003 Jan 1;6(6):709.

Dykstra LA, Granger AL, Allen RM, Zhang X, Rice KC. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure. Psychopharmacology (Berl). 2002 Oct 1;163(3-4):420-9.

Allen RM, Granger AL, Dykstra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys. J Pharmacol Exp Ther. 2002 Feb 1;300(2):435-41.

Allen RM, Granger AL, Dykstra LA. LY235959 potentiates the antinociceptive effects of morphine, l-methadone, levorphanol, butorphanol, and buprenorphine in a primate titration procedure. Poster presented at the College on the Problems of Drug Dependence; 2001.

Dysktra LA, Granger AL. Interactions between the delta agonist SNC80, and the mu agonists, morphine, buprenorphine, and butorphanol in squirrel monkeys. Nida Res Monogr. 2000;180:65.

Allen RM, Granger AL, Dysktra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist snc80 in a primate shock titration procedure. Poster presented at the College on the Problems of Drug Dependence; 2000.

Rosen JB, Granger AL, Walker EA. Nalbuphine drug discriminations: effects of opioid peptide ctap. Poster presented at the 1st International Meeting of the Behavioral Pharmacology Society and European Behavioral Pharmacology Society; 1999.